All In Biotech

Drug Trial Radar · NCT00665223

A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease

A Multicentre, Multinational, Randomised, Double-Blind, Parallel-Group Study Comparing ACR16 45 mg Once-Daily or Twice-Daily Versus Placebo for the Symptomatic Treatment of Huntington's Disease

Last checked: Nov 19, 2026Latest source record: Aug 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 437 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

437

Actual

Start

Apr 24, 2008

Primary completion

Jun 14, 2010

Study completion Jun 14, 2010

Sponsor

Sponsor type
Industry
First posted
Apr 23, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if ACR16 is effective and safe in the symptomatic treatment of Huntington's disease.

Conditions

  • Huntington's Disease

Interventions

  • ACR16Drug

    Capsules will be swallowed whole with water.

  • PlaceboDrug

    Capsules will be swallowed whole with water.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Modified Motor Score (mMS) (Sum of Score of Items 4-10 and 13-15 of the Unified Huntington's Disease Rating Scale [UHDRS] Motor Assessments) at Week 26Time frame: Baseline, Week 26

Locations

31 sites in 8 countries. Site status is shown where the registry gives one.

  • LKH -Univ. Klinikum Graz, Universitaetsklinik fur Psychiatrie Graz

    Graz, Styria, Austria

  • Innsbruck Medical University, Anichstraße 35

    Innsbruck, Tyrol, Austria

  • University Hospital Gasthuisberg

    Leuven, Flemish Brabant, Belgium

  • CHU Roger Salengro

    Lille, Hauts-de-France, France

  • Hôpital Purpan, Place Docteur-Baylac, Bâtiment F

    Toulouse, Midi-Pyrénées Region, France

  • Hôpital Nord, CHU d'Amiens, Service de Neurologie

    Amiens, Picardie, France

  • CHU La Timone, 264 Rue Saint Pierre

    Marseille, Provence-Alpes-Côte d'Azur Region, France

  • Klinik für Psychiatrie und Psychotherapie, Charité - Universitätsmedizin Berlin, Schumannstrasse 20/21

    Berlin, Germany

  • Universitätsklinik Ulm, Neurologie/ Oberer Eselberg 45/1

    Ulm, Baden-Wurttemberg, Germany

  • Klinikum rechts der Isar der Technischen Universität München, Neurologische Klinik und Poliklinik, Ismaninger Str. 22

    München, Bavaria, Germany

  • Isar Amper Klinikum gemeinnützige GmbH, Klinik Taufkirchen (Vils), Bräuhausstr.5

    Taufkirchen (Vils), Bavaria, Germany

  • St. Josef Hospital, Ruhr University Bochum, Gudrunstraße 56

    Bochum, North Rhine-Westphalia, Germany

  • Westfaelische Wilhelms-Universitaet Muenster, Klinik fur Neurologie

    Münster, North Rhine-Westphalia, Germany

  • Universitat Dresden, Klinikum Carl Gustav Carus, Fetscherstr. 74

    Dresden, Saxony, Germany

  • Fondazione IRCCS Istituto Nazionale Neurologico "Carlos Besta", Department of Movement Disorders, 11 via Celoria

    Milan, Lombardy, Italy

  • IRCCS Neuromed, Localita Camarelle

    Pozzilli, Molise, Italy

  • Centro de Estudos Egas Moniz, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz

    Lisbon, Portugal

  • University Hospital of Coimbra, Av. Rissaya Barreto

    Coimbra, Baixo Mondego, Portugal

  • Hospital Clinic of Barcelona, Calle Villarroel, 170

    Barcelona, Spain

  • Hospital Ramon y Cajal, Carretera Colemenar km 9.100

    Madrid, Spain

  • Hospital Universitario La Fe, Avda. Campanar 21,

    Valencia, Spain

  • Hospital Mútua de Terrassa, C/ Castell

    Terrassa, Catalonia, Spain

  • Cambridge Centre for Brain repair, Cambridge University

    Cambridge, United Kingdom

  • R&D Headquarters, Barberry Centre, 25 Vincent Drive

    Birmingham, England/West Midlands, United Kingdom

  • Department of Clinical Genetics, St Mary's Hospital, Hathersage Road

    Manchester, North West England, United Kingdom

  • First Floor Argyll House, Fosterhill, Cornhill Road

    Aberdeen, Scotland, United Kingdom

  • SE Scotland Genetic Service, Western General Hospital, Crewe Road

    Edinburgh, Scotland, United Kingdom

  • Churchill Hospital, Old Road, Headington

    Oxford, South East England, United Kingdom

  • Academic Neurology Unit, E Floor Medical School Beech Hill Road

    Sheffield, South Yorkshire, United Kingdom

  • Institute of Human Genetics, Centre for Life, Central Parkway

    Newcastle upon Tyne, Tyne and Wear, United Kingdom

  • Cardiff University School of Medicine, Department of Neurology & Medical Genetics, Heath Park

    Cardiff, Wales, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.